Merck wins CPhI Award with Parteck® MXP for Excellence in Pharmaceutical Excipients

We congratulate Merck for winning the Award with Parteck® MXP excipient for hot melt extrusion. Here some information on the product:

Enhanced API Solubility and Stable, High Drug Loads

Poor solubility of APIs is a critical challenge in drug development. One formulation technique to address this challenge is hot melt extrusion (HME). Our new Parteck® MXP is a polyvinyl alcohol-based excipient designed for hot melt extrusion to increase solubility and allow for stable and high drug loads for a broad range of APIs. The polymer  has a long safety record related to its usage in drugs and is generally recognized as safe (GRAS) by the U.S. Food and Drug Administration. Parteck® MXP complies with USP,  Ph. Eur., and JPE monographs.

More on Parteck® MXP

You might also like